Specialized insurance coverage for every link in the medical supply chain – from ambulance fleets to biologics cold chain. Backed by Munich Re and Swiss Re.
Medical logistics is one of the highest-risk sectors in healthcare operations. Every transport event carries the potential for patient harm, cargo loss, regulatory exposure, and catastrophic liability – often simultaneously and across multiple jurisdictions.
Since 1984, J.D. Insurance has engineered coverage solutions for medical transport operators, pharmaceutical distributors, air ambulance services, and cold chain logistics networks. Our programs are designed around the operational realities of healthcare logistics – not adapted from general freight insurance.
Every program is engineered to the specific risk profile of your operation. No boilerplate. No general freight adaptation.
Ambulance fleets, air medical transport, and non-emergency medical transport operations. Covers patient injury liability, vehicle incidents, and medical error during transport events.
High-value pharmaceutical shipments, controlled substances, and biologics. Coverage triggers include theft, damage, contamination, and customs seizure across all licensed geographies.
Temperature-controlled supply chain protection including deviation events, equipment failure, power loss, and carrier default. Purpose-built for biologics, vaccines, and temperature-sensitive pharmaceuticals.
Multi-modal coverage across all transport categories. Single master policy framework covering all modes of transport with coordinated claims management and a unified premium structure.
FDA and customs violations occurring during transport, including documentation failures and import/export compliance actions. Covers legal defense costs and regulatory penalty payments across 28 licensed countries.
Business interruption coverage triggered by logistics network failures, partner insolvency, or force majeure events affecting medical transport operations. Revenue-based calculation methodology.
Summary of coverage categories, risk events, geographic scope, and triggers. Detailed policy terms provided upon engagement.
| Coverage Category | Risk Events Covered | Geographic Scope | Coverage Trigger |
|---|---|---|---|
| Patient Transport | Accidents, patient injury, medical error during transport | All licensed geographies | Per incident |
| Pharmaceutical Cargo | Theft, damage, spoilage, contamination | Worldwide | CIF value of cargo |
| Cold Chain | Temperature deviation, equipment failure, power loss | Worldwide | Per shipment deviation event |
| Air Medical Transport | Aircraft incidents, diversion, mechanical failure | International | Per event + liability |
| Regulatory Fines | Import/export violations, documentation failures | 28 licensed countries | Per regulatory action |
| Business Interruption | Loss of transport network, partner failure | All operating geographies | Revenue-based calculation |
Coverage matrix is illustrative. Actual terms, sublimits, and exclusions are defined in the master policy document. Contact your account manager for detailed specifications.
Temperature-sensitive pharmaceuticals – biologics, vaccines, gene therapies, monoclonal antibodies – represent an unprecedented convergence of high value, strict regulatory requirements, and catastrophic failure modes. A single deviation event can destroy an entire shipment and trigger regulatory notification obligations across multiple jurisdictions simultaneously.
J.D.'s cold chain coverage is built around the operational reality of modern pharmaceutical distribution: multi-carrier networks, intermodal transfers, customs dwell time, and last-mile challenges that expose product to risk at every handoff. Our policies trigger at the point of deviation – not at the point of discovery.
"A single cold chain failure in a vaccine distribution network can destroy millions in product and expose the operator to catastrophic liability."
Expand each section for detailed policy parameters. All terms subject to underwriting review and final policy language.
Patient transport coverage encompasses all licensed ambulance operations, air medical services, and non-emergency medical transport (NEMT) fleets. Primary coverage components include general liability per occurrence, patient injury liability, vehicle physical damage, on-board medical equipment replacement, and driver/crew professional liability.
Coverage applies to accredited medical transport providers with active licenses in their operating jurisdictions. Air medical transport programs require FAA or equivalent authority certification. NEMT operators must maintain current state licensing and vehicle inspections.
Sublimits apply to passenger personal effects, medical equipment aboard, and cyber liability for dispatch and patient record systems. Contact your account manager for fleet-specific program design.
Pharmaceutical cargo insurance covers declared shipment value on a CIF (Cost, Insurance, Freight) basis. Coverage applies from the point of origin through to delivery confirmation, including all intermediate storage, customs dwell time, and multi-carrier handoffs.
Controlled substances require DEA or equivalent authority licensing documentation at time of policy binding. Biologics, blood products, and cellular therapies are covered under specialized endorsements that account for their particular spoilage and liability profiles.
High-value single shipments exceeding $1M USD require advance notification and may be subject to enhanced security requirements. Worldwide coverage includes all 28 J.D.-licensed jurisdictions plus transit coverage through international waters and airspace.
Cold chain coverage applies to any pharmaceutical product with a declared temperature specification – including refrigerated (2–8°C), frozen (−20°C), ultra-cold (−70°C and below), and controlled room temperature (CRT) products. Coverage triggers at the point of documented temperature excursion.
Policyholders are required to maintain continuous temperature monitoring with data logger or IoT sensor systems. Coverage disputes resolved using certified temperature records; estimated or reconstructed records are not accepted.
Per-shipment deductibles apply. Multi-shipment annual programs with aggregate deductibles are available for high-volume distributors. Biological product spoilage includes regulatory notification costs as a covered expense.
Regulatory fines coverage protects against penalties assessed by the FDA, U.S. Customs & Border Protection, DEA, and equivalent international regulatory authorities arising from incidents during transport operations. Covered actions include import refusals, customs seizures, GDP (Good Distribution Practice) compliance failures, and documentation deficiencies.
Legal defense costs are covered on a first-dollar basis with no deductible for regulatory matters. J.D. maintains relationships with specialized pharmaceutical regulatory law firms in all 28 licensed jurisdictions.
Coverage does not apply to intentional violations, willful misconduct, or pre-existing regulatory matters known at the time of policy binding. Criminal proceedings are excluded but civil regulatory actions and administrative appeals are fully covered.
Emergency response coverage provides business interruption protection when a medical logistics operation is disrupted by qualifying events including natural disasters, pandemic-related network failures, partner carrier insolvency, infrastructure failure (port closures, airspace restrictions), and cybersecurity incidents affecting dispatch or routing systems.
Revenue replacement is calculated on the basis of verified prior-period revenue for the affected network segment. Coverage begins after a 48-hour waiting period and continues for up to 12 months. Extended indemnity periods available by endorsement.
Emergency response also covers the cost of alternative transport procurement, including chartered air freight, emergency courier services, and temporary cold storage facilities activated during a network disruption event.
All inquiries are handled by senior account managers with direct medical logistics experience. No intake queues.
Corporate Inquiry →